Effect of crocetin on blood pressure restoration and synthesis of inflammatory mediators in heart after hemorrhagic shock in anesthetized rats

Shock

Volumn 33, Issue 1, 2010, Pages 83-87

  Yan, Junling ^a   Qian, Zhiyu ^a   Sheng, Liang ^a,b   Zhao, Bohua ^a   Yang, Lina ^a   Ji, Hui ^a   Han, Xiaoyuan ^a   Zhang, Rong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cardiac injury; IL 6; INOS; Nuclear factor kappa B; Oxidative stress; Reactive oxygen species; Superoxide dismutase; TNF

Indexed keywords

CROCETIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MALONALDEHYDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; HEART; HEART INJURY; HEMORRHAGIC SHOCK; IMMUNE RESPONSE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; RESUSCITATION;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CAROTENOIDS; HEART; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MALONDIALDEHYDE; MYOCARDIUM; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITROGEN OXIDES; RATS; SHOCK, HEMORRHAGIC; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73849101127     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181a98f55     Document Type: Article

References (32)

1. Meldrum DR, Shenkar R, Sheridan BC, Cain BS, Abraham E, Harken AH: Hemorrhage activates myocardial NF.B and increases TNF-a in the heart. J Mol Cell Cardiol 29(10):2849-2854, 1997.
2. Mauriz JL, Matilla B, Culebras JM, González P, González-Gallego J: Dietary glycine inhibits activation of nuclear factor kappa B and prevents liver injury in hemorrhagic shock in the rat. Free Radic Biol Med 31(10):1236-1244, 2001.
3. Savoye G, Tamion F, Richard V, Varin R, Thuillez C: Hemorrhagic shock resuscitation affects early and selective mesenteric artery endothelial function through a free radical-dependent mechanism. Shock 23(5):411-416, 2005.
4. Sato H, Tanaka T, Kasai K, Kita T, Tanaka N: Role of p38 mitogenYactivated protein kinase on cardiac dysfunction after hemorrhagic shock in rats. Shock 28(3):291-299, 2007.
5. Zhong Z, Enomoto N, Connor HD, Moss N, Mason RP, Thurman RG: Glycine improves survival after hemorrhagic shock in the rat. Shock 12(1):54-62, 1999.
6. Tamion F, Richard V, Bonmarchand G, Leroy J, Hiron M, Daveau M, Thuillez C, Lebreton JP: Reduced synthesis of inflammatory cytokines by a free radical scavenger after hemorrhagic shock in rats. Crit Care Med 28(7):2522-2527, 2000.
7. Mota-Filipe H, McDonald MC, Cuzzocrea S, Thiemermann C: A membranepermeable radical scavenger reduces the organ injury in hemorrhagic shock. Shock 12(4):255-261, 1999.
8. Izumi M, McDonald MC, Sharpe MA, Chatterjee PK, Thiemermann C: Superoxide dismutase mimetics with catalase activity reduce the organ injury in hemorrhagic shock. Shock 18(3):230-235, 2002.
9. Ahmad AS, Ansari MA, Ahmad M, Saleem S, Yousuf S, Hoda MN, Islam F: Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacol Biochem Behav 81(4):805-813, 2005.
10. Wang CJ, Lee MJ, Chang MC, Lin JK: Inhibition of tumor promotion in benzo[a]pyrene-initiated CD-1 mouse skin by crocetin. Carcinogenesis 16(2): 187-191, 1995.
11. Tseng TH, Chu CY, Huang JM, Shiow SJ, Wang CJ: Crocetin protects against oxidative damage in rat primary hepatocytes. Cancer Lett 97(1): 61-67, 1995.
12. Zheng S, Qian Z, Tang F, Sheng L: Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits. Biochem Pharmacol 70(8):1192-1199, 2005.
13. Giassi LJ, Gilchrist MJ, Graham MC, Gainer JL: Trans sodium crocetinate restores blood pressure, heart rate, and plasma lactate after hemorrhagic shock. J Trauma 51(5):932-938, 2001.
14. Van Way CW 3rd, Dhar A, Morrison DC, Longorio MA, Maxfield DM: Cellular energetics in hemorrhagic shock: Restoring adenosine triphosphate to the cells. J Trauma 54(Suppl 5):S169-S176, 2003.
15. Singer M, Stidwill RP, Nathan A, Gainer JL: Intravenous crocetinate prolongs survival in a rat model of lethal hypoxemia. Crit Care Med 28(6):1968-1972, 2000.
16. Jarrar D, Wang P, Cioffi WG, Bland KI, Chaudry IH: Critical role of oxygen radicals in the initiation of hepatic depression after trauma hemorrhage. J Trauma 49(5):879-885, 2000.
17. Giassi LJ, Kennon PA, Gainer JL: Trans sodium crocetinate for hemorrhagic shock: Effect of time delay in initiating therapy. Shock 18(6):585-588, 2002.
18. Giassi LJ, Gainer JL: TSC and hemorrhagic shock. Adv Exp Med Biol 540: 55-60, 2003.
19. Liu TZ, Qian ZY: Study on pharmacokinetics and tissue distributions of crocetin in rats by RP-HPLC. Chin J Pharm anal 24(2):149-153, 2002.
20. Szabo C, Billiar TR: Novel roles of nitric oxide in hemorrhagic shock. Shock 12(1):1-9, 1999.
21. Barnes PJ, Karin M: Nuclear factor kappa B: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336(15):1066-1071, 1997.
22. Altavilla D, Deodato B, Campo GM, Arlotta M, Miano M, Squadrito G: IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-κB and reduces the inflammatory response in myocardial ischaemireperfusion injury. Cardiovasc Res 47(3):515-528, 2000.
23. Altavilla D, Saitta A, Guarini S, Galeano M, Squadrito G, Cucinotta D: Oxidative stress causes nuclear factor-kappa B activation in acute hypovolemic hemorrhagic shock. Free Radic Biol Med 30(10):1055-1066, 2001.
24. Meng ZH, Dyer K, Billiar TR, Tweardy DJ: Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am J Physiol Cell Physiol 280(2):C343-C351, 2001.
25. Collins JL, Vodovotz Y, Hierholzer C, Villavicencio RT, Liu S, Alber S: Characterization of the expression of inducible nitric oxide synthase in rat and human liver during hemorrhagic shock. Shock 19(2):117-122, 2003.
26. Balaszczuk AM, Arreche ND, Mc Laughlin M, Arranz C, Fellet AL: Nitric oxide synthases are involved in the modulation of cardiovascular adaptation in hemorrhaged rats. Vascul Pharmacol 44(6):417-426, 2006.
27. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D: Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53(1):135-159, 2001. (Pubitemid 32173112)
28. Szabó C: The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 6(2):79-88, 1996.
29. Lander HM: An essential role for free radicals and derived species in signal transduction. FASEB J 11(2):118-124, 1997.
30. Kapoor R, Prasad K: Role of oxyradicals in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion: Effect of SOD and catalase. Circ Shock 43(2):79-94, 1994.
31. Douzinas EE, Pitaridis MT, Patsouris E, Kollias S, Boursinos V, Karmpaliotis DI, Gratsias Y: Myocardial ischemia in intestinal postischemic shock: The effect of hypoxemic reperfusion. Crit Care Med 31(8):2183-2189, 2003.
32. Tharakan B, Hunter FA, Smythe WR, Childs EW: Alpha-lipoic acid attenuates hemorrhagic shock-induced apoptotic signaling and vascular hyperpermeability. Shock 30(5):571-577, 2008.